cuprizone has been researched along with Body Weight in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 4 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anyaegbu, C; Bartlett, CA; Fitzgerald, M; Hellewell, SC; Lins, B; McGonigle, T; Papini, M; Toomey, LM; Warnock, A; Wright, AJ | 1 |
| Baumann, L; Beecken, M; Greiner, T; Heinig, L; Joost, S; Kipp, M; Manzhula, K; Schauerte, S; Vankriekelsvenne, E | 1 |
| Behrangi, N; Frank, M; Joost, S; Kipp, M; Mann, T; Zhan, J | 1 |
| Jin, L; Li, Y; Liu, C; Loers, G; Petridis, AK; Siebert, HC; Wang, Z; Yin, X; Zhang, N; Zhang, R; Zheng, X | 1 |
| Afolabi, T; Gbadamosi, IT; Jaji-Sulaimon, R; Kolo, RM; Omotoso, GO | 1 |
| Kipp, M; Leopold, P; Schmitz, C | 1 |
| Emrich, M; Heneka, MT; Krauthausen, M; Müller, M; Saxe, S; Zimmermann, J | 1 |
| Bercury, KK; Macklin, WB; Narayanan, SP; Popescu, DC; Sachs, HH | 1 |
| Berlow, Y; Bourdette, D; Chalupsky, M; Chaudhary, P; Johnson, M; O'Connor, A; Pollaro, J; Rooney, W; Tagge, I; Woltjer, R | 1 |
| Ács, P; Bölcskei, K; Kemény, Á; Komoly, S; Pintér, E; Pohóczky, K; Sághy, É; Sándor, Z; Sétáló, G; Sipos, É; Szőke, É | 1 |
| Browning, R; Clough, RW; Li, XM; Wang, H; Xiao, L; Xu, H; Yang, HJ; Zhang, Y | 1 |
| Gregg, JR; Hanlin, RP; Herring, NR; Konradi, C; Naydenov, AV | 1 |
| Cai, QY; Chen, XS; Liu, YL; Su, L; Xu, Y; Yao, ZX; Ye, JN; Zhan, XL; Zhao, SF | 1 |
| Kusnecov, AW; Urbach-Ross, D | 1 |
| Hiremath, MM; Knapp, GW; Matsushima, GK; Saito, Y; Suzuki, K; Ting, JP | 1 |
| Dayan, AD; Garrod, IJ; Purves, DC | 1 |
1 review(s) available for cuprizone and Body Weight
| Article | Year |
|---|---|
The Cuprizone Model: Dos and Do Nots.
Topics: Animals; Body Weight; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Gene Expression Regulation; Multiple Sclerosis | 2020 |
15 other study(ies) available for cuprizone and Body Weight
| Article | Year |
|---|---|
Cuprizone feed formulation influences the extent of demyelinating disease pathology.
Topics: Animal Feed; Animals; Astrocytes; Body Weight; Chelating Agents; Corpus Callosum; Cuprizone; Demyelinating Diseases; Disease Models, Animal; DNA Damage; Gliosis; Inflammation; Male; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Oligodendroglia; Reproducibility of Results | 2021 |
The Cuprizone Mouse Model: A Comparative Study of Cuprizone Formulations from Different Manufacturers.
Topics: Animals; Body Weight; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Gliosis; Male; Mice; Mice, Inbred C57BL; Myelin Sheath | 2023 |
Amelioration of clinical course and demyelination in the cuprizone mouse model in relation to ketogenic diet.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Astrocytes; Body Weight; Brain; Chemokine CXCL10; Cuprizone; Cytokines; Demyelinating Diseases; Diet, Ketogenic; Disease Models, Animal; Down-Regulation; Glial Fibrillary Acidic Protein; Histone Deacetylases; Inflammasomes; Male; Mice; Mice, Inbred C57BL; Microglia; Myelin Basic Protein; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Weight Loss | 2020 |
Moringa oleifera Ameliorates Histomorphological Changes Associated with Cuprizone Neurotoxicity in the Hippocampal Cornu ammonis (CA) 3 Region.
Topics: Animals; Body Weight; Cuprizone; Hippocampus; Moringa oleifera; Neurotoxicity Syndromes; Plant Extracts; Rats, Wistar | 2018 |
Animal Weight Is an Important Variable for Reliable Cuprizone-Induced Demyelination.
Topics: Animals; Body Weight; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Female; Male; Mice; Mice, Inbred C57BL; Reproducibility of Results | 2019 |
CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system.
Topics: Analysis of Variance; Animals; Antigens, CD; Body Weight; Cuprizone; Cytokines; Demyelinating Diseases; Flow Cytometry; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Monoamine Oxidase Inhibitors; Neuroglia; Receptors, CXCR3; RNA, Messenger | 2014 |
A new model of cuprizone-mediated demyelination/remyelination.
Topics: Analysis of Variance; Animals; Basic Helix-Loop-Helix Transcription Factors; Body Weight; Brain; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Immunosuppressive Agents; Ki-67 Antigen; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Myelin Sheath; Myelin-Oligodendrocyte Glycoprotein; Nerve Tissue Proteins; Oligodendrocyte Transcription Factor 2; Oligodendroglia; Receptor, Platelet-Derived Growth Factor alpha; Sirolimus | 2014 |
Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model.
Topics: Animals; Body Weight; Brain; Corpus Callosum; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Myelin Sheath; Transcriptome | 2016 |
TRPA1 deficiency is protective in cuprizone-induced demyelination-A new target against oligodendrocyte apoptosis.
Topics: Adenomatous Polyposis Coli; Animals; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; Body Weight; Brain; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Fibroblast Growth Factor 2; Gene Expression Regulation; Gliosis; Mice; Mice, Knockout; Monoamine Oxidase Inhibitors; Myelin Basic Protein; Nerve Tissue Proteins; Oligodendroglia; Signal Transduction; TRPA1 Cation Channel | 2016 |
Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia.
Topics: Animal Feed; Animals; Behavior, Animal; Body Weight; Chelating Agents; Copper; Cuprizone; Demyelinating Diseases; Male; Mice; Mice, Inbred C57BL; Myelin Sheath; Nerve Fibers, Myelinated; Neuropil; Oligodendroglia; Prosencephalon; Schizophrenia | 2009 |
Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats.
Topics: Age Factors; Animals; Attention; Body Weight; Corpus Striatum; Cuprizone; Down-Regulation; Eating; Gene Expression Profiling; Hippocampus; Locomotion; Male; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Oligodendroglia; Oligonucleotide Array Sequence Analysis; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Reflex, Startle | 2009 |
Progesterone alleviates neural behavioral deficits and demyelination with reduced degeneration of oligodendroglial cells in cuprizone-induced mice.
Topics: Animals; Apoptosis; Behavior, Animal; Body Weight; Caspase 3; Cuprizone; Demyelinating Diseases; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Oligodendroglia; Progesterone; Rotarod Performance Test | 2013 |
Effects of acute and repeated exposure to lipopolysaccharide on cytokine and corticosterone production during remyelination.
Topics: Acute Disease; Animals; Body Weight; CD11b Antigen; Chelating Agents; Chronic Disease; Corpus Callosum; Corticosterone; Cuprizone; Cytokines; Demyelinating Diseases; Disease Models, Animal; Leukocyte Common Antigens; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Myelin Basic Protein; Myelin Sheath; Nerve Regeneration; Spleen | 2007 |
Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.
Topics: Animals; Astrocytes; Body Weight; Brain; Cell Count; Chelating Agents; Copper; Corpus Callosum; Cuprizone; Demyelinating Diseases; Dose-Response Relationship, Drug; Liver; Macrophages; Male; Mice; Mice, Inbred C57BL; Microglia; Myelin Sheath; Time Factors | 1998 |
A comparison of spongiosis induced in the brain by hexachlorophene, cuprizone and triethyl tin in the Sprague-Dawley rat.
Topics: Animals; Body Weight; Brain; Brain Edema; Cuprizone; Dose-Response Relationship, Drug; Drinking; Eating; Hexachlorophene; Male; Organ Size; Rats; Rats, Inbred Strains; Triethyltin Compounds; Vacuoles | 1991 |